Patents by Inventor Tibor Sipos

Tibor Sipos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100021505
    Abstract: Method of preventing or reducing diarrhea and/or steatorrhea in HIV-positive patients being treated with High Activity Antiretroviral drugs containing protease inhibitors, nucleoside reverse transcriptase inhibitors or non-nucleoside reverse transcriptase inhibitors. The method includes the steps of: administering to the HIV-positive patient a High Activity Antiretroviral drug containing a protease inhibitor, a nucleoside reverse transcriptase inhibitor or a non-nucleoside reverse transcriptase inhibitor; and co-administering with the HAART drug a gastric acid-resistant polymer-coated and buffered digestive enzyme composition containing pancreatic proteases, lipases, co-lipases, nucleases, amylases and other bio-active substances produced by the pancreatic gland.
    Type: Application
    Filed: July 28, 2008
    Publication date: January 28, 2010
    Inventors: TIBOR SIPOS, SIMANTINI DAS, TERESE MARIE WIGNOT
  • Publication number: 20040197321
    Abstract: Method of preventing or reducing diarrhea and correcting fat malabsorption (steatorrhea) and loss of body mass in HIV-positive patients being treated with High Activity Antiretroviral drugs (HAART) containing protease inhibitors, nucleoside reverse transcriptase inhibitors or non-nucleoside reverse transcriptase inhibitors and by co-administering with the HAART a buffered pancrelipase composition. The method includes the steps of: administering to the HIV-positive patient a High Activity Antiretroviral drug containing a protease inhibitor, a nucleoside reverse transcriptase inhibitor or a non-nucleoside reverse transcriptase inhibitor; and co-administering with the HAART drug a gastric acid-resistant polymer-coated and buffered pancrelipase enzyme composition containing pancreatic proteases, lipases, co-lipases, nucleases, amylases and other bio-active substances produced by the pancreatic gland.
    Type: Application
    Filed: April 8, 2004
    Publication date: October 7, 2004
    Inventors: Tibor Sipos, Simantini Das, Terese Marie Wignot
  • Publication number: 20030180279
    Abstract: Method of preventing or reducing diarrhea and/or steatorrhea in HIV-positive patients being treated with High Activity Antiretroviral drugs containing protease inhibitors, nucleoside reverse transcriptase inhibitors or non-nucleoside reverse transcriptase inhibitors. The method includes the steps of: administering to the HIV-positive patient a High Activity Antiretroviral drug containing a protease inhibitor, a nucleoside reverse transcriptase inhibitor or a non-nucleoside reverse transcriptase inhibitor; and co-administering with the HAART drug a gastric acid-resistant polymer-coated and buffered digestive enzyme composition containing pancreatic proteases, lipases, co-lipases, nucleases, amylases and other bio-active substances produced by the pancreatic gland.
    Type: Application
    Filed: March 19, 2002
    Publication date: September 25, 2003
    Inventors: Tibor Sipos, Simantini Das, Teresa Marie Wignot
  • Patent number: 5750104
    Abstract: Disclosed are gastric acid-resistant polymer-coated buffered digestive enzymes/bile acid compositions, process for their preparations and methods of treating digestive disorders and cystic fibrosis by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: May 29, 1996
    Date of Patent: May 12, 1998
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5614223
    Abstract: Disclosed are controlled rate-release devices for releasing a pharmaceutically active agent into the oral cavity by the dissolving action of the saliva, a process of preparing such devices and methods of preventing/treating conditions/diseases in a mammal by delivering a pharmaceutically active substance into the oral cavity.
    Type: Grant
    Filed: July 17, 1995
    Date of Patent: March 25, 1997
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5578304
    Abstract: Disclosed are gastric acid-resistant polymer-coated, buffered digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods for treating digestive disorders, pancreatic enzyme insufficiency, impaired liver function, and cystic fibrosis for regulating the absorption of dietary iron and cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: May 4, 1995
    Date of Patent: November 26, 1996
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5460812
    Abstract: Disclosed are gastric acid-resistant polymer-coated buffered digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods of treating digestive disorders, pancreatic enzyme insufficiency, impaired liver function, cystic fibrosis, for regulating the absorption of dietary iron and cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: September 29, 1993
    Date of Patent: October 24, 1995
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5433952
    Abstract: Disclosed are controlled rate-release devices for releasing a pharmaceutically active agent into the oral cavity by the dissolving action of the saliva, and a method of preparing such devices.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: July 18, 1995
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5415872
    Abstract: Disclosed are buffer-stabilized gastric acid resistant polymer-coated bile salt compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, preventing colon cancer, cholestasis associated with cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: October 20, 1993
    Date of Patent: May 16, 1995
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5405621
    Abstract: Disclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, preventing colon cancer, cholestasis associated with cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: November 10, 1993
    Date of Patent: April 11, 1995
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5352460
    Abstract: Disclosed are gastric acid-resistant polymer-coated ursodeoxycholate compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of colon cancer following cholecystectomy, cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: May 24, 1993
    Date of Patent: October 4, 1994
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5352682
    Abstract: Disclosed are compositions containing bile acid-aminosalicylate conjugates having the formula, or a pharmaceutically acceptable salt thereof ##STR1## wherein R.sub.1 is OH either the .alpha. or the .beta. position;R.sub.2 is OH;R.sub.3 is H or OH; andR.sub.4 is H or acetyl,the process for their preparation and method of treating/preventing gastrointestinal disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, colon cancer, inflammatory bowel diseases, Crohn's disease, cystic fibrosis, dissolving gallstones, and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: March 8, 1993
    Date of Patent: October 4, 1994
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5324514
    Abstract: Disclosed are gastric acid-resistant polymer-coated digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods of treating digestive disorders, treating impaired liver function, treating cystic fibrosis, regulating the absorption of dietary cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: August 11, 1993
    Date of Patent: June 28, 1994
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5302400
    Abstract: Disclosed are gastric acid-resistant polymer-coated digestive enzymes/buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, cystic fibrosis, regulating the absorption of dietary cholesterol, and for dissolving gallstones by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: June 22, 1992
    Date of Patent: April 12, 1994
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5262172
    Abstract: Disclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of colon cancer following cholecystectomy, cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: November 16, 1993
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5260074
    Abstract: Disclosed are gastric acid-resistant polymer-coated digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, cystic fibrosis, regulating the absorption of dietary cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: June 22, 1992
    Date of Patent: November 9, 1993
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5234697
    Abstract: Disclosed are gastric acid-resistant polymer-coated ursodeoxycholate compositions, process for their preparations and-methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of colon cancer following cholecystectomy, cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.
    Type: Grant
    Filed: June 22, 1992
    Date of Patent: August 10, 1993
    Assignee: Digestive Care Inc.
    Inventor: Tibor Sipos
  • Patent number: 5137449
    Abstract: A system for long term releasing of medication in the mouth, and especially an intra-oral fluoride releasing system (IFRS) for releasing fluoride over a long term for inhibiting the formation of caries in the teeth. The system uses a holder for retaining and protecting intra-oral fluoride tablets or other intra-oral medicament in the form of fluoride releasing devices (IFRD). The holder has a plate with retaining sides and retaining posts or a carrier. The tablet will fit within the holder. The tablet may be located in the carrier, or ligature bands can be tied around the tablet in order to releasably hold the IFRD within the holder. The system causes a level of fluoride to be maintained over a long term within the mouth which has been found chemically effective for caries control and without causing severe irritation to oral tissues.
    Type: Grant
    Filed: June 2, 1989
    Date of Patent: August 11, 1992
    Assignees: Johnson & Johnson Consumer Products, Inc., Eastman Dental Center
    Inventors: Bruce Goldin, Ronald J. Billings, Tibor Sipos, Bruce E. Kohut, Kathleen Woodward
  • Patent number: 5049077
    Abstract: A system for long term releasing of medication in the mouth, and especially an intra-oral fluoride releasing system (IFRS) for releasing fluoride over a long term for inhibiting the formation of caries in the teeth. The system uses a holder for retaining and protecting intra-oral fluoride tablets or other intra-oral medicament in the form of fluoride releasing devices (IFRD). The holder has a plate with retaining sides and retaining posts or a carrier. The tablet will fit within the holder. The tablet may be located in the carrier, or ligature bands can be tied around the tablet in order to releasably hold the IFRD within the holder. The system causes a level of fluoride to be maintained over a long term within the mouth which has been found chemically effective for caries control and without causing severe irritation to oral tissues.
    Type: Grant
    Filed: March 20, 1989
    Date of Patent: September 17, 1991
    Assignees: Johnson & Johnson Consumer Products, Inc., Eastman Dental Center
    Inventors: Bruce Goldin, Ronald J. Billings, Tibor Sipos, Bruce E. Kohut, Kathleen Woodward
  • Patent number: 4664906
    Abstract: Oral compositions which exhibit antimicrobial activity containing hexedine and a pharmaceutically acceptable zinc compound.
    Type: Grant
    Filed: August 30, 1984
    Date of Patent: May 12, 1987
    Assignee: Johnson & Johnson Products Inc.
    Inventor: Tibor Sipos